Evidence map›Paper›PMID 35692828›Full record

ArticleFrontiers in genetics2022

The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC.

Yuhong Huang, Han Liu, Xuena Liu, Nan Li, Han Bai, Chenyang Guo, Tian Xu, Lei Zhu, Chao Liu, Jing Xiao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yuhong HuangDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Han LiuDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Xuena LiuDepartment of Nuclear Medicine, The 2nd Hospital Affiliated to Dalian Medical University, Dalian, China.
Nan LiDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Han BaiDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Chenyang GuoDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Tian XuDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Lei ZhuDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Chao LiuDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Jing XiaoDepartment of Oral Pathology, School of Stomatology, Dalian Medical University, Dalian, China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CCL5CXCLimmune checkpoint blockade (ICB)PD-1/PD-L1squamous cell carcinoma of head and neck (HNSCC)tumor-associated monocyte/macrophage (TAMM)tumor micro-environment (TME)

Identifiers

PMID35692828
PMCPMC9186378
OpenAlexW4281805011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.